Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection
暂无分享,去创建一个
Mario Roederer | S. Rowland-Jones | H. Whittle | R. Koup | A. McMichael | M. Roederer | D. Ambrozak | A. Jaye | Assan Jaye | Melody G. Duvall | Melissa L. Precopio | David A. Ambrozak | Andrew J. McMichael | Hilton C. Whittle | Sarah L. Rowland‐Jones | Richard A. Koup | M. Precopio | M. Duvall | Melody G. Duvall | Andrew J. McMichael | Sarah L. Rowland-Jones | Hilton C. Whittle | A. J. McMichael
[1] F. Gao,et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. McElrath,et al. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. , 1999, The Journal of infectious diseases.
[3] M. Melbye,et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa , 1997, The Lancet.
[4] Annapurna Vyakarnam,et al. Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection1 , 2002, The Journal of Immunology.
[5] A. Hill,et al. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. , 1993, Journal of immunology.
[6] Mario Roederer,et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses , 2007, The Journal of experimental medicine.
[7] H. Whittle,et al. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. , 1998, Journal of human virology.
[8] Steve Kaye,et al. Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation , 2007, Journal of Virology.
[9] Laurie Lamoreaux,et al. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. , 2006, Journal of immunological methods.
[10] L. Pinto,et al. T‐helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals , 1995, Journal of medical virology.
[11] Z. Grossman,et al. HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.
[12] M. Clerici,et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.
[13] Mario Roederer,et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells , 2003, Nature Medicine.
[14] B. Thiers,et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2008 .
[15] B. Walker,et al. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. , 2007, Immunity.
[16] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[17] H. Whittle,et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. , 2002, AIDS research and human retroviruses.
[18] G. Pantaleo,et al. Functional Heterogeneity of Memory CD4 T Cell Responses in Different Conditions of Antigen Exposure and Persistence1 , 2005, The Journal of Immunology.
[19] Jeffrey N. Martin,et al. Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment , 2005, Journal of Virology.
[20] R. Koup,et al. Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations , 2007, European journal of immunology.
[21] L. Borysiewicz,et al. Subsets of CD8 +, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses , 1993, Clinical and experimental immunology.
[22] S. Popper,et al. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. , 1999, Journal of Human Virology.
[23] Mario Roederer,et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.
[24] R. Koup,et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation , 2006, The Journal of experimental medicine.
[25] H. Whittle,et al. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. , 1996, The Journal of infectious diseases.
[26] J. Falloon,et al. Vaccination in Humans Generates Broad T Cell Cytokine Responses1 , 2004, The Journal of Immunology.
[27] G. Pantaleo,et al. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] H. Whittle,et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. , 1994, AIDS research and human retroviruses.
[29] A. E. Sousa,et al. Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. , 2001, The Journal of infectious diseases.
[30] Anthony D. Kelleher,et al. Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.
[31] P. Henkart. Mechanism of lymphocyte-mediated cytotoxicity. , 1985, Annual review of immunology.
[32] H. Whittle,et al. Cytotoxic T Cells from Human Immunodeficiency Virus Type 2-Infected Patients Frequently Cross-React with Different Human Immunodeficiency Virus Type 1 Clades , 1998, Journal of Virology.
[33] S. Rowland-Jones,et al. Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection1 , 2006, The Journal of Immunology.
[34] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[35] S. Rowland-Jones,et al. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV‐2) and type 1 (HIV‐1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype , 2005, European journal of immunology.
[36] S. Rowland-Jones,et al. HIV-2 and T cell recognition. , 1998, Current opinion in immunology.
[37] P. Lehner,et al. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. , 1995, Journal of immunology.
[38] G. Pantaleo,et al. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. , 2004, Blood.
[39] Z. Grossman,et al. HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity , 2003, The Journal of experimental medicine.
[40] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[41] H. Whittle,et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia , 2002, AIDS.
[42] J. Albert,et al. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. , 1999, Virology.
[43] J. Bluestone,et al. The role of cytoplasmic granules in cytotoxicity by large granular lymphocytes and cytotoxic T lymphocytes. , 1985, Advances in experimental medicine and biology.
[44] H. Whittle,et al. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. , 2004, The Journal of infectious diseases.
[45] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[46] Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. , 2000, AIDS research and human retroviruses.
[47] G. Gottlieb,et al. Comparison of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses in HIV-1- and HIV-2-Infected Individuals in Senegal , 2004, Journal of Virology.
[48] D. Price,et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry , 2006, Nature Medicine.
[49] H. Whittle,et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa , 2000, AIDS.
[50] Anthony D Kelleher,et al. Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. , 2004, Blood.
[51] Alison Johnson,et al. Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 , 2003, Journal of Virology.